Huntsman Corporation Annual report pursuant to Section 13 and 15(d)

Note 13 - Restructuring, Impairment and Plant Closing Costs (Credits) (Tables)

12 Months Ended

Dec. 31, 2020

							*Non-cancelable*			*Other*
	*Workforce*			*Demolition and*			*lease and contract*			*restructuring*
	*reductions*			*decommissioning*			*termination costs*			*costs*			*Total*
Accrued liabilities as of January 1, 2018	$	5		$	2		$	41		$	5		$	53
2018 charges for 2017 and prior initiatives		—			—			2			—			2
2018 charges for 2018 initiatives		5			—			—			10			15
2018 payments for 2017 and prior initiatives		(2	)		(1	)		(2	)		—			(5	)
2018 payments for 2018 initiatives		(1	)		—			—			(5	)		(6	)
Reversal of reserves no longer required		(2	)		—			(29	)		—			(31	)
Accrued liabilities as of December 31, 2018		5			1			12			10			28
2019 (credits) charges for 2018 and prior initiatives		2			(1	)		2			3			6
2019 charges for 2019 initiatives		7			—			—			1			8
2019 payments for 2018 and prior initiatives		(4	)		—			(7	)		(9	)		(20	)
2019 payments for 2019 initiatives		—			—			—			(1	)		(1	)
Reversal of reserves no longer required		(2	)		—			—			(2	)		(4	)
Accrued liabilities as of December 31, 2019		8			—			7			2			17
2020 charges for 2019 and prior initiatives		—			—			2			3			5
2020 charges for 2020 initiatives		35			—			—			3			38
2020 payments for 2019 and prior initiatives		(5	)		—			(7	)		(4	)		(16	)
2020 payments for 2020 initiatives		(10	)		—			—			(3	)		(13	)
Reversal of reserves no longer required		—			—			—			(1	)		(1	)
Foreign currency effect on liability balance		1			—			—			—			1
Accrued liabilities as of December 31, 2020	$	29		$	—		$	2		$	—		$	31

				*Performance*			*Advanced*			*Textile*			*Corporate*
	*Polyurethanes*			*Products*			*Materials*			*Effects*			*and other*			*Total*
Accrued liabilities as of January 1, 2018	$	1		$	1		$	3		$	47		$	1		$	53
2018 charges (credits) for 2017 and prior initiatives		—			1			—			(4	)		5			2
2018 charges for 2018 initiatives		—			2			3			—			10			15
2018 payments for 2017 and prior initiatives		(1	)		(1	)		—			—			(3	)		(5	)
2018 payments for 2018 initiatives		—			(1	)		—			—			(5	)		(6	)
Reversal of reserves no longer required		—			(1	)		—			(29	)		(1	)		(31	)
Accrued liabilities as of December 31, 2018		—			1			6			14			7			28
2019 charges for 2018 and prior initiatives		—			—			—			2			4			6
2019 charges for 2019 initiatives		—			—			7			—			1			8
2019 payments for 2018 and prior initiatives		—			(1	)		(2	)		(9	)		(8	)		(20	)
2019 payments for 2019 initiatives		—			—			(1	)		—			—			(1	)
Reversal of reserves no longer required		—			—			—			(4	)		—			(4	)
Accrued liabilities as of December 31, 2019		—			—			10			3			4			17
2020 charges (credits) for 2019 and prior initiatives		—			1			(1	)		1			4			5
2020 charges for 2020 initiatives		16			4			9			7			2			38
2020 payments for 2019 and prior initiatives		(1	)		—			(5	)		(2	)		(8	)		(16	)
2020 payments for 2020 initiatives		(3	)		(3	)		(3	)		(2	)		(2	)		(13	)
Reversal of reserves no longer required		—			—			(1	)		—			—			(1	)
Foreign currency effect on liability balance		—			—			—			1			—			1
Accrued liabilities as of December 31, 2020	$	12		$	2		$	9		$	8		$	—		$	31

Current portion of restructuring reserves	$	12		$	2		$	6		$	6		$	—		$	26
Long-term portion of restructuring reserves		—			—			3			2			—			5

Cash charges:
2020 charges for 2019 and prior initiatives	$	5
2020 charges for 2020 initiatives		38
Reversal of reserves no longer required		(1	)
Noncash charges:
Accelerated depreciation		7
Total 2020 restructuring, impairment and plant closing costs	$	49

Cash charges:
2019 charges for 2018 and prior initiatives	$	6
2019 charges for 2019 initiatives		8
Reversal of reserves no longer required		(4	)
Noncash charges:
Gain on sale of assets		(49	)
Other noncash credits		(2	)
Total 2019 restructuring, impairment and plant closing costs	$	(41	)

Cash charges:
2018 charges for 2017 and prior initiatives	$	2
2018 charges for 2018 initiatives		15
Noncash charges:
Reversal of reserves no longer required		(31	)
Other noncash charges		7
Total 2018 restructuring, impairment and plant closing costs	$	(7	)